Skip to content
  • Monday, 12 October 2026
  • 6:16 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Teva Pharmaceutical Industries Secures FDA Approval for Weltruza, a Once-Monthly Injectable Olanzapine to Transform Schizophrenia Care
Pharmaceutical R&D

Teva Pharmaceutical Industries Secures FDA Approval for Weltruza, a Once-Monthly Injectable Olanzapine to Transform Schizophrenia Care

Teuku Ryan Oct 12, 2026 0

The landscape of neuropsychiatric care has reached a significant milestone following the United States Food and Drug Administration (FDA) approval…

Read More
The biotech bi-weekly: a disease modeling research grant and an accelerator program for data-driven health start-upsNew IVF method mimics fallopian tube environment, increasing sperm viabilityLilly Ascends to Pharma’s Top Revenue Spot Amidst Landmark Oral GLP-1 Approval, Yet Wall Street Remains UnconvincedStroke triggers a hidden brain change that looks like rejuvenation
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic Proportions
2026 PharmSci 360 adds tracks on research credibility and post-animal drug developmentTeva Pharmaceutical Industries Secures FDA Approval for Weltruza, a Once-Monthly Injectable Olanzapine to Transform Schizophrenia CareTWiV 1288: Clinical update with Dr. Daniel Griffin | Microbe TVScientists discover a hidden factor that can make or break chemical reactions
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
2026 PharmSci 360 adds tracks on research credibility and post-animal drug development
Lana Keisha Oct 12, 2026
Pharmaceutical R&D
Teva Pharmaceutical Industries Secures FDA Approval for Weltruza, a Once-Monthly Injectable Olanzapine to Transform Schizophrenia Care
Teuku Ryan Oct 12, 2026
Microbiology & Immunology
TWiV 1288: Clinical update with Dr. Daniel Griffin | Microbe TV
Lina Irawan Oct 12, 2026
Advanced Materials Science
Scientists discover a hidden factor that can make or break chemical reactions
Nila Kartika Wati Oct 12, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ